“Summary
Piramal Enterprises Limited (PEL), formerly Piramal Healthcare Limited, is a pharmaceutical company that operates across sectors such as life sciences, health care, financial services, health care information management, specialty glass packaging and real estate. The company also offers contract manufacturing and development services. It offers pharma solutions, critical care solutions, imaging services, bio-orthopedics, phytomedicines and consumer products. Its critical care products include inhalation anesthetics and Propofol and plasma volume expanders. PEL also concentrates on research and commercialization of herbal medicines and natural products. Its target therapy areas include diabetes, arthritis, obesity, constipation, liver damage, anxiety, sexual dysfunction, cough and cold. The company operates through its offices located in India, Sri Lanka, the UK, France, Germany, Italy, Canada, and the US. PEL is headquartered in Mumbai, Maharashtra, India.
Piramal Enterprises Limited (PEL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.”
“Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Piramal Enterprises Limited, Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Piramal Enterprises Limited, Medical Equipment Deals By Type, 2009 to YTD 2015 7
Piramal Enterprises Limited, Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Piramal Enterprises Limited, Medical Equipment, Deals By Market, 2009 to YTD 2015 9
Piramal Enterprises Limited, Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Piramal Enterprises Limited, Medical Equipment, Deal Details 11
Asset Purchase 11
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11
Partnerships 12
Piramal Imaging Enters Into Licensing Agreement With Ci-Co Healthcare For Florbetaben F18 12
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 13
IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben 14
Piramal Healthcare Terminates Its Distribution Agreement With DiaSorin 15
AC Immune Enters Into License Agreement With Piramal Imaging 16
Equity Offering 18
Piramal Healthcare Plans To Raise US$217 Million 18
Asset Transactions 19
DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 19
Acquisition 20
Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 20
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 22
ARKRAY Acquires 49% Stake In ARKRAY PIRAMAL Medical From Piramal Healthcare 24
Piramal Healthcare Completes Acquisition Of BioSyntech 25
Nicholas Piramal India Acquires MINRAD INTERNATIONAL 26
Piramal Enterprises Limited – Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 33
Financial Announcements 33
Aug 06, 2015: Piramal Consolidated Results for the First Quarter ended 30 June 2015 33
May 07, 2015: Piramal Enterprises Consolidated Results for the Fourth Quarter and Full Year ended 31 March 2015 35
Feb 09, 2015: Piramal Enterprises Consolidated Results for the Third Quarter and Nine Months ended 31 December 2014 38
Oct 21, 2014: Piramal Enterprises announces Q2 & H1FY2015 results 40
Aug 06, 2014: Piramal Enterprises Announces Q1 FY2015 Results 41
Jan 30, 2014: Piramal Enterprises Announces Q3 results for the Quarter ended December 31, 2013 42
Research And Development 43
Aug 28, 2014: Piramal Enterprises To Exit Early Drug Discovery Research 43
Other Significant Developments 44
Jan 13, 2015: Piramal Enterprises’ Pharma Solution division receives four CMO Leadership Awards 2015 44
Mar 27, 2014: Piramal Enterprises Receives GLP Compliance Certificate from NGCMA for its Research & Development Facility Located in Mumbai, India 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46″
“List of Tables
Piramal Enterprises Limited, Medical Equipment, Key Facts, 2015 1
Piramal Enterprises Limited, Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Piramal Enterprises Limited, Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Piramal Enterprises Limited, Medical Equipment Deals By Type, 2009 to YTD 2015 7
Piramal Enterprises Limited, Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Piramal Enterprises Limited, Deals By Market, 2009 to YTD 2015 9
Piramal Enterprises Limited, Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11
Piramal Imaging Enters Into Licensing Agreement With Ci-Co Healthcare For Florbetaben F18 12
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 13
IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben 14
Piramal Healthcare Terminates Its Distribution Agreement With DiaSorin 15
AC Immune Enters Into License Agreement With Piramal Imaging 16
Piramal Healthcare Plans To Raise US$217 Million 18
DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 19
Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 20
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 22
ARKRAY Acquires 49% Stake In ARKRAY PIRAMAL Medical From Piramal Healthcare 24
Piramal Healthcare Completes Acquisition Of BioSyntech 25
Nicholas Piramal India Acquires MINRAD INTERNATIONAL 26
Piramal Enterprises Limited, Key Competitors 28
Piramal Enterprises Limited, Key Employees 29
Piramal Enterprises Limited, Other Locations 30
Piramal Enterprises Limited, Subsidiaries 31″
“List of Figures
Piramal Enterprises Limited, Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Piramal Enterprises Limited, Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Piramal Enterprises Limited, Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Piramal Enterprises Limited, Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Piramal Enterprises Limited, Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Piramal Enterprises Limited, Medical Equipment, Deals by Type, 2009 to YTD 2015 7
Piramal Enterprises Limited, Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Piramal Enterprises Limited, Medical Equipment, Deals by Market, 2009 to YTD 2015 9″